Effects of optimized-SopungSunkiwon on memory impairment and enhancement

Neuroscience Letters

Volumn 491, Issue 2, 2011, Pages 93-98

  Choi, Jin Gyu ^a   Yang, Woong Mo ^a   Kang, Tong Ho ^a   Oh, Myung Sook ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Alzheimer's disease; Memory; OSS; Synapse

Indexed keywords

ACETYLCHOLINESTERASE; BRAIN PROTEIN; DONEPEZIL; HERBACEOUS AGENT; OPTIMIZED SOPUNGSUNKIWON; POSTSYNAPTIC DENSITY PROTEIN 95; SCOPOLAMINE; SYNAPTOPHYSIN; TACRINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEMENTIA; DRUG EFFECT; ENZYME ACTIVITY; IMMUNOHISTOCHEMISTRY; LATENT PERIOD; MALE; MEMORY DISORDER; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; SINGLE DRUG DOSE; SYNAPSE;

ACETYLCHOLINESTERASE; ANIMALS; ANTHRAQUINONES; AVOIDANCE LEARNING; BRAIN; CAROTENOIDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; IMMUNOHISTOCHEMISTRY; IRIDOIDS; MALE; MAZE LEARNING; MEDICINE, KOREAN TRADITIONAL; MEMORY; MEMORY DISORDERS; MICE; MICE, INBRED ICR; NEUROPROTECTIVE AGENTS; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL;

EID: 79951581001     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.12.058     Document Type: Article

References (20)

1. Bartus R.T., Dean R.L., Beer B., Lippa A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982, 217:408-414.
2. Clare R., King V.G., Wirenfeldt M., Vinters H.V. Synapse loss in dementias. J. Neurosci. Res. 2010, 88:2083-2090.
3. Court J.A., Perry E.K. Dementia: the neurochemical basis of putative transmitter orientated therapy. Pharmacol. Ther. 1991, 52:423-443.
4. Das A., Shanker G., Nath C., Pal R., Singh S., Singh H. A comparative study in rodents of standardized extracts of Bacopa monniera and Ginkgo biloba: anticholinesterase and cognitive enhancing activities. Pharmacol. Biochem. Behav. 2002, 73:893-900.
5. Davies P., Maloney A.J. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 1976, 2:1403.
6. Deiana S., Harrington C.R., Wischik C.M., Riedel G. Methylthioninium chloride reverses cognitive deficits induced by scopolamine: comparison with rivastigmine. Psychopharmacology (Berl) 2009, 202:53-65.
7. Ebert K. Scopolamine model of dementia: electroencephalogram findings and cognitive performance. Eur. J. Clin. Invest. 1998, 28:944-949.
8. El-Husseini A.E., Schnell E., Chetkovich D.M., Nicoll R.A., Bredt D.S. PSD-95 involvement in maturation of excitatory synapses. Science 2000, 290:1364-1368.
9. Neuropathology: A Reference Text of CNS Pathology 2004, Mosby, London. D. Ellison, S. Love, L. Chimelli, B. Harding, J.S. Lowe, H.V. Vinters (Eds.).
10. Ellman G.L., Courtney K.D., Andres V., Feather-Stone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961, 7:88-95.
11. Francis P.T., Palmer A.M., Snape M., Wilcock G.K. The cholinergic hypothesis of Alzheimer's disease: a review of progress. J. Neurol. Neurosurg. Psychiatry 1999, 66:137-147.
12. Kim D.H., Yoon B.H., Kim Y.W., Lee S., Shin B.Y., Jung J.W., Kim H.J., Lee Y.S., Choi J.S., Kim S.Y., Lee K.T., Ryu J.H. The seed extract of Cassia obtusifolia ameliorates learning and memory impairments induced by scopolamine or transient cerebral hypoperfusion in mice. J. Pharmacol. Sci. 2007, 105:82-93.
13. Kim Y.Y., Kang H.J., Ko S.K., Chung S.H. Sopungsungi-won (SP) prevents the onset of hyperglycemia and hyperlipidemia in Zucker diabetic fatty rats. Arch. Pharm. Res. 2002, 25:923-931.
14. Kim Y.Y., Kang K.M., Chung S.H. Long-term administration of Sopungsungi-won (SP) prevents diabetic nephropathy in Zucker diabetic fatty rats. Arch. Pharm. Res. 2002, 25:917-922.
15. O'Brien J.T., Ballard C.G. Drugs for Alzheimer's disease. BMJ 2001, 323:123-124.
16. Oh M.S., Huh Y., Bae H., Ahn D.K., Park S.K. The multi-herbal formula Guibi-tang enhances memory and increases cell proliferation in the rat hippocampus. Neurosci. Lett. 2005, 379:205-208.
17. Rao A., Kim E., Sheng M., Craig A.M. Heterogeneity in the molecular composition of excitatory postsynaptic sites during development of hippocampal neurons in culture. J. Neurosci. 1998, 18:1217-1229.
18. Behavioural Neuroscience 1993, Oxford University Press, Oxford. A. Sahgal (Ed.).
19. Sakata Y., Chida R., Ishige K., Edagawa Y., Tadano T., Ito Y. Effect of a nutritive-tonic drink on scopolamine-induced memory impairment in mice. Biol. Pharm. Bull. 2005, 28:1886-1891.
20. Wright C.I., Geula C., Mesulam M.M. Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability. Ann. Neurol. 1993, 34:373-384.